MMRGlobal to Launch Innovative Scanning Solution at HIMSS 2014
LOS ANGELES, CA--(Marketwired - Feb 18, 2014) - MMRGlobal, Inc.
(OTCQB: MMRF), through its wholly owned subsidiary
MyMedicalRecords, Inc. (collectively, "MMR"), today announced that
it will launch MMRProPlus at the HIMSS14 Annual Conference &
Exhibition starting next week on February 23rd in Orlando, Florida,
Booth #875 (www.HIMSSConference.org). MMRProPlus is an
integrated, end-to-end document scanning and imaging solution that
works with any scanner. MMRProPlus also brings the power of
the original MMRPro system to any healthcare professional including
small group medical practices, urgent care facilities, ambulatory
surgical centers and hospitals. The MMRProPlus system has been
designed to work with virtually any Windows-based or Mac OS system
at one-third the cost of the original MMRPro network scanning
solution. MMRProPlus is the most cost-effective way for
healthcare professionals to scan and digitize medical records while
also providing patients timely online access to their personal
health information through MMRPatientView or MyMedicalRecords.
MMRProPlus also integrates seamlessly with most existing
practice management and EMR systems. Users of the MMRProPlus system
simply install MMRProPlus drivers on the PC that is connected to
the scanner to be used. If the scanner is wireless then multiple
PCs can be configured. Nothing is installed on a scanner,
everything happens on the client PC. The system also enables
providers to create custom patient forms on demand and tracks
patient data and medical records using advanced bar code capture
technology.
Visitors to HIMSS14 can see MMRProPlus and MMR's entire lineup
of products and services in Booth #875, February 23rd through the
26th. Also presenting in the booth will be Company licensees
4medica and Interbit Data.
All of MMRGlobal's products and services, including the new
MMRProPlus system, the MyMedicalRecords Personal Health Record,
MyEsafeDepositBox.com virtual vault, and MMRPatientView utilize
MMR's patented technologies which include ten U.S. patents: U.S.
Patent Nos. 8,117,045; 8,117,646; 8,121,855; 8,301,466; 8,321,240;
8,352,287; 8,352,288; 8,498,883; 8,626,532; and 8,645,161. The MMR
patent portfolio also includes numerous issued patents and pending
applications in other countries or regional authorities of
commercial interest including Australia, Singapore, New Zealand,
Mexico, Japan, Canada, China, Hong Kong, South Korea, Israel and
Europe. Using MMRPro, healthcare professionals can move away
from handling paper based records while seamlessly integrating with
most EMR, EHR or PHR systems mandated under the HITECH Act, paving
the way for the implementation of fully-functional interoperable
certified EMR systems.
About MMRGlobal MMRGlobal, Inc., through its wholly-owned
operating subsidiary, MyMedicalRecords, Inc., provides secure and
easy-to-use online Personal Health Records ("PHRs") and electronic
safe deposit box storage solutions, serving consumers, healthcare
professionals, employers, insurance companies, financial
institutions, retail pharmacies, and professional organizations and
affinity groups. The MyMedicalRecords PHR enables individuals and
families to access their medical records and other important
documents, such as birth certificates, passports, insurance
policies and wills, anytime from anywhere using the Internet.
MyMedicalRecords is built on proprietary, patented technologies to
allow documents, images and voicemail messages to be transmitted
and stored in the system using a variety of methods, including fax,
phone, or file upload without relying on any specific electronic
medical record platform to populate a user's account. The Company's
professional offering, MMRPro, is designed to give physicians'
offices an easy and cost-effective solution to digitizing
paper-based medical records and sharing them with patients through
an integrated patient portal. Through its merger with Favrille,
Inc. in January 2009, the Company acquired intellectual property
biotech assets that include anti-CD20 antibodies and data and
samples from its FavId™/Specifid™ vaccine clinical trials for the
treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about
MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video
tutorials of the Company's products and services at
www.mmrtheater.com.
Forward-Looking Statements All statements in this press release
that are not strictly historical in nature, including, without
limitation, future performance, management's expectations, beliefs,
intentions, estimates or projections, constitute "forward-looking
statements." Such forward-looking statements involve known and
unknown risks, uncertainties and other factors that may cause MMR's
actual results to be materially different from historical results
or from any results expressed or implied by such forward-looking
statements. Some can be identified by the use of words (and their
derivations) such as "need," "possibility," "potential," "intend,"
"offer," "development," "if," "negotiate," "when," "begun,"
"believe," "achieve," "will," "estimate," "expect," "maintain,"
"plan," and "continue," or the negative of these words. Actual
outcomes and results of operations and the timing of selected
events may differ materially from the results predicted, and any
reported results should not be considered as an indication of
future performance. Such statements are necessarily based on
assumptions and estimates and are subject to various risks and
uncertainties, including those relating to the possible invalidity
of the underlying assumptions and estimates and possible changes or
developments in economic, business, industry, market, legal and
regulatory circumstances and conditions and actions taken or
omitted to be taken by third parties, including customers,
suppliers, business partners, potential licensees, competitors and
legislative, judicial and other governmental authorities and
officials. Factors that could cause or contribute to such
differences include, but are not limited to: unexpected outcomes
with respect to intellectual property enforcement actions, claims
of intellectual property infringement and general intellectual
property litigation; our ability to maintain, develop, monetize and
protect our patent portfolio for both MMR's health IT and
biotechnology intellectual property assets in the U.S. and
internationally; our ability to establish and maintain strategic
relationships; changes in our relationships with our licensees; the
risk MMR's products are not adopted or viewed favorably by the
healthcare community and consumer retail market; business
prospects, results of operations or financial condition; risks
related to the current uncertainty and instability in financial and
lending markets, including global economic uncertainties; the
timing and volume of sales and installations; the length of sales
cycles and the installation process; the market's acceptance of new
product and service introductions; competitive product offerings
and promotions; changes in government laws and regulations
including the 2009 HITECH Act and changes in Meaningful Use and the
2010 Affordable Care Act; future changes in tax legislation and
initiatives in the healthcare industry; undetected errors in our
products; the possibility of interruption at our data centers;
risks related to third party vendors; risks related to obtaining
and integrating third-party licensed technology; risks related to a
security breach by third parties; risks associated with recruitment
and retention of key personnel; other litigation matters;
uncertainties associated with doing business internationally across
borders and territories; and additional risks discussed in MMR's
filings with the Securities and Exchange Commission. MMR is
providing this information as of the date of this release and,
except as required by applicable law, does not undertake any
obligation to update any forward-looking statements contained in
this release as a result of new information, future events or
otherwise.
CONTACT: Michael Selsman Public Communications Co.
ms@publiccommunications.biz (310)
922-7033